• Log in
Greater Manchester Medicines Management Group - GMMMG logo
  • Home
    • Homepage
    • News Summary
    • Consultations
  • Joint Formulary
  • RAG/DNP
    • Adult RAG list
    • Paediatric RAG List
  • Shared Care
    • Approved Shared Care Protocols
  • GMMMG Guidance
    • Clinical guidance and pathways
    • Antimicrobial guidance and resources
    • Information leaflets for primary care prescribers
    • Medicines and devices recommendations
    • Seven minute briefings
    • High cost drugs
    • Prescribing policies
    • Operational policies
    • Primary care rebate schemes
  • Meetings
    • Membership and Terms of Reference
    • Decision Summaries
    • GMMMG Meetings
    • Clinical Reference Group
    • GMMMG Process Documents
    • Subgroup Meetings Archives
Home » News Summary » GMMMG incretin therapy update

GMMMG incretin therapy update

GMMMG have issued an update on incretin therapies in Greater Manchester. Please cascade to your colleagues and relevant networks.

Other GMMMG advice on incretin therapies is available on the Clinical Guideance and Pathways page.

GMMMG Incretin Therapy Update June v2Download

GMMMG Consultations

Complete a consultation form »

GMMMG Members Area

Access members area »

Search GMMMG

Latest news

  • GMMMG decisions approved – July 2026

    September 2026

  • GMMMG decisions approved – June 2026

    August 2026

  • New consultation: CRG actions August 2026

    August 2026

Follow GMMMG on Twitter

  • Terms and Conditions
  • Contact
  • About us
  • RSS Feed
This website use a combination of essential and non-essential cookies to give you the best on-site experience.
You can change your non-essential cookie choice at any time by using the Change non-essential cookie choice button.